Kliniska studier för Lupus i North Carolina
20 studier för Lupus söker deltagare vid platser i North Carolina.
Städer i North Carolina
Officiell studietext (engelska)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50238, Charlotte
RekryterarFas 3
Ålder 16 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06617325A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- DJL Clinical Research, PLLC, Charlotte
- Cross Creek Medical Clinic, PA, Fayetteville
RekryterarFas 2
Ålder 18 till 74 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07409181An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, Durham
RekryterarFas 3
Ålder 5 till 17 · Alla kön · Uppdaterad 30 sep. 2026 · NCT05835310A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Joint and Muscle Research Institute, Charlotte
- DJL Clinical Research, PLLC, Charlotte
- Cross Creek Medical Clinic, Fayetteville
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07438496Anifrolumab Pregnancy Study
- Research Site, Cary
RekryterarObservationsstudie
Ålder 18 till 130 · Kvinnor · Uppdaterad 18 sep. 2026 · NCT07049653A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, Chapel Hill
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 15 sep. 2026 · NCT06916806A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Arthritis and Osteoporosis Consultants of the Carolinas II, LLC, Charlotte
- Superior Clinical Research, LLC, Smithfield
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07355218A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Cross Creek Medical Clinic, Fayetteville
RekryterarFas 2
Ålder 12 till 70 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07570862A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, Chapel Hill
- Research Site, Charlotte
RekryterarFas 1/2
Ålder 18 till 70 · Alla kön · Uppdaterad 10 sep. 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Atrium Health Rheumatology-Southpark, Charlotte
- Duke University Medical Center, Durham
RekryterarFas 1
Ålder 18 till 74 · Alla kön · Uppdaterad 10 sep. 2026 · NCT07085104A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- DJL Clinical Research, PLLC, Charlotte
RekryterarObservationsstudie
Ålder 16 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT07175285Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
- Research Site, Wilmington
RekryterarObservationsstudie
Alla åldrar · Kvinnor · Uppdaterad 2 sep. 2026 · NCT06659029A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- University of North Carolina TraCS Institute - CTRC, Chapel Hill
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 28 aug. 2026 · NCT06925542RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- UNC Chapel Hill, Chapel Hill
RekryterarFas 1/2
Ålder 18 till 65 · Alla kön · Uppdaterad 26 aug. 2026 · NCT06121297Intervention to Improve Communication and Medication Adherence in Lupus
- Duke University, Durham
Rekryterar
Ålder 18 till 90 · Alla kön · Uppdaterad 17 aug. 2026 · NCT06458075A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Duke University, Durham
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 14 juli 2026 · NCT07115745A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Duke University Health System, Durham
RekryterarFas 1
Ålder 12 till 70 · Alla kön · Uppdaterad 22 maj 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- UNC Chapel Hill, Chapel Hill
RekryterarObservationsstudie
Ålder 18 till 110 · Alla kön · Uppdaterad 15 apr. 2026 · NCT05934149Duke Lupus Registry
- Duke University Medical Center, Durham
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 8 jan. 2026 · NCT00512694Maternal Autoimmune Disease Research Alliance (MADRA) Registry
- Duke University, Durham
RekryterarObservationsstudieFriska volontärer välkomna
Alla åldrar · Kvinnor · Uppdaterad 8 jan. 2026 · NCT03276923Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.